Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aim Immunotech, Akston, Ascendis, Astrazeneca, Bharat Biotech, Clover, Daiichi Sankyo, Eiger, Epimab, Evgen, Gan and Lee, Hutchmed, Innate, Jiangsu Nhwa, Johnson & Johnson, Nrx, Ocugen, Oryzon Genomics, Rakuten Medical, Reithera, Takeda, Tetherex, Transcenta, Trevena, Zydus Cadila.